Law Firms Urge Charming Medical Investors to Seek Lead Role in Securities Case

Overview

• On December 29, The Schall Law Firm and DJS Law Group issued notices inviting MCTA shareholders to contact them about serving as lead plaintiff by February 17, 2026.
• The firms identify a proposed class period of October 21 to November 12, 2025, while a separate Robbins LLP filing cites October 10 to November 12, 2025.
• The SEC suspended trading in November 2025 during an investigation into claims that supposed financial advisors touted Charming Medical on social media to inflate the share price.
• Complaints allege the company made false or misleading statements during the class period and that investors suffered losses when relevant information came to light.
• Robbins LLP alleges impersonated financial professionals and the use of offshore or nominee accounts to dump shares, and reports that trading remains halted, while the class has not yet been certified and absent investors are not currently represented.